Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Edwards Lifesciences Corp (EW)

Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 48,948,304
  • Shares Outstanding, K 580,300
  • Annual Sales, $ 5,440 M
  • Annual Income, $ 4,175 M
  • EBIT $ 1,385 M
  • EBITDA $ 1,540 M
  • 60-Month Beta 0.95
  • Price/Sales 8.43
  • Price/Cash Flow 30.94
  • Price/Book 4.86

Options Overview Details

View History
  • Implied Volatility 31.58% (+0.17%)
  • Historical Volatility 18.93%
  • IV Percentile 73%
  • IV Rank 39.55%
  • IV High 52.16% on 04/08/25
  • IV Low 18.11% on 08/28/25
  • Expected Move (DTE 32) 5.73 (6.79%)
  • Put/Call Vol Ratio 0.27
  • Today's Volume 2,416
  • Volume Avg (30-Day) 1,330
  • Put/Call OI Ratio 1.28
  • Today's Open Interest 90,530
  • Open Int (30-Day) 90,578
  • Expected Range 78.62 to 90.08

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 31 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.61
  • Number of Estimates 12
  • High Estimate 0.63
  • Low Estimate 0.60
  • Prior Year 0.59
  • Growth Rate Est. (year over year) +3.39%

Price Performance

See More
Period Period Low Period High Performance
1-Month
81.26 +3.80%
on 01/14/26
87.44 -3.53%
on 12/29/25
-0.97 (-1.14%)
since 12/16/25
3-Month
72.67 +16.07%
on 10/17/25
87.89 -4.03%
on 12/05/25
+11.70 (+16.10%)
since 10/16/25
52-Week
65.94 +27.92%
on 04/09/25
87.89 -4.03%
on 12/05/25
+14.49 (+20.74%)
since 01/16/25

Most Recent Stories

More News
What to Expect From Edwards Lifesciences' Q4 2025 Earnings Report

Edwards Lifesciences is expected to announce its fiscal fourth-quarter earnings soon, and analysts project a single-digit earnings growth.

EW : 84.35 (-0.17%)
XLV : 155.74 (-0.78%)
$SPX : 6,940.01 (-0.06%)
Edwards Comments on JenaValve Acquisition

Edwards Lifesciences (NYSE: EW) today announced that the U.S. District Court for the District of Columbia has granted the motion from the U.S. Federal Trade Commission (FTC) for an injunction blocking...

EW : 84.35 (-0.17%)
HALPER SADEH LLC ENCOURAGES EDWARDS LIFESCIENCES CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

EW : 84.35 (-0.17%)
FDA Approves Edwards Lifesciences' SAPIEN M3 Mitral Valve Replacement System as First Transseptal Transcatheter Therapy

Edwards Lifesciences (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system is the first transcatheter therapy utilizing a transseptal approach to receive U.S. Food and Drug...

EW : 84.35 (-0.17%)
Stocks Rebound on Strength in Chip Stocks and a Benign US CPI Report

The S&P 500 Index ($SPX ) (SPY ) today is up by +0.79%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.59%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up by +1.43%. December E-mini S&P futures...

MSTR : 173.71 (+1.64%)
AMAT : 327.01 (+2.49%)
CNK : 23.93 (-2.17%)
SNDK : 413.62 (+1.07%)
GLXY : 34.31 (+7.25%)
MRK : 108.83 (-1.93%)
$IUXX : 25,529.26 (-0.07%)
COIN : 241.15 (+0.78%)
ASML : 1,358.57 (+2.03%)
DJT : 13.87 (+1.54%)
ZNH26 : 111-220 (-0.06%)
ESH26 : 6,910.00 (-0.96%)
Edwards Lifesciences to Present at the 44th Annual J.P. Morgan Healthcare Conference

Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the J.P. Morgan Healthcare Conference on Monday, Jan. 12, 2026. Bernard Zovighian, chief executive officer,...

EW : 84.35 (-0.17%)
Edwards Lifesciences Reaffirms Strategy for Sustainable, Differentiated Growth at Annual Investor Conference

Innovation with Purpose, Powered by Science, Centered on Patients: Edwards’ Commitment to Drive Value for the Healthcare Ecosystem

EW : 84.35 (-0.17%)
How Is Edwards Lifesciences’ Stock Performance Compared to Other Medical Device Stocks?

Edwards Lifesciences has notably outperformed the broader market over the past year, and analysts remain bullish on the stock’s prospects.

EW : 84.35 (-0.17%)
SYK : 363.78 (+0.36%)
IHI : 61.83 (-0.95%)
HALPER SADEH LLC ENCOURAGES EDWARDS LIFESCIENCES CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

EW : 84.35 (-0.17%)
Edwards Lifesciences Stock: Is Wall Street Bullish or Bearish?

Although Edwards Lifesciences has outpaced the broader market over the past year, analysts remain measured in their expectations, maintaining a cautiously optimistic view as they look for continued execution...

EW : 84.35 (-0.17%)
XLV : 155.74 (-0.78%)
$SPX : 6,940.01 (-0.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair...

See More

Key Turning Points

3rd Resistance Point 86.12
2nd Resistance Point 85.34
1st Resistance Point 84.84
Last Price 84.35
1st Support Level 83.56
2nd Support Level 82.78
3rd Support Level 82.28

See More

52-Week High 87.89
Last Price 84.35
Fibonacci 61.8% 79.51
Fibonacci 50% 76.92
Fibonacci 38.2% 74.32
52-Week Low 65.94

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar